A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors Post author: Post published:May 6, 2026 Post category: Continue ReadingA Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
AB-1002 in Patients With Class III Heart Failure Post author: Post published:May 6, 2026 Post category: Continue ReadingAB-1002 in Patients With Class III Heart Failure
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression Post author: Post published:May 6, 2026 Post category: Continue ReadingA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis Post author: Post published:May 6, 2026 Post category: Continue ReadingKYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
RAPA-501 Therapy of ALS Expanded Access Protocol Post author: Post published:May 6, 2026 Post category: Continue ReadingRAPA-501 Therapy of ALS Expanded Access Protocol
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) Post author: Post published:May 6, 2026 Post category: Continue ReadingSafety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Autologous Gene Therapy for Artemis-Deficient SCID Post author: Post published:May 6, 2026 Post category: Continue ReadingAutologous Gene Therapy for Artemis-Deficient SCID
Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis Post author: Post published:May 6, 2026 Post category: Continue ReadingStudy to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis
Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury Post author: Post published:May 6, 2026 Post category: Continue ReadingIltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial) Post author: Post published:May 6, 2026 Post category: Continue ReadingA Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
